From idea to pilot-ready agentic application
Audit trails, guardrails, and governance controls
Clinical evidence to post-market surveillance
Our intelligent agents autonomously generate, validate, and deliver mission-critical reports across the entire MedTech value chain.
Summarize and assess clinical evidence to demonstrate the safety, performance, and clinical benefit of a medical device in line with regulatory requirements.
Document findings from clinical investigations conducted to evaluate device safety, performance, and intended use in real-world or study settings.
Monitor real-world device performance through complaints, incidents, feedback, and surveillance data to support ongoing safety and regulatory oversight.
Capture post-market clinical follow-up activities used to generate ongoing clinical evidence, confirm device performance, and support lifecycle compliance.
Assess device usability, user interaction, and use-related risks to demonstrate that intended users can operate the device safely and effectively.
Evaluate identified hazards, risk controls, and overall benefit-risk profile to support product safety, compliance, and quality decision-making.
Document product changes, validation activities, and technical assessments to ensure modifications are controlled, verified, and compliant.
Provide periodic summaries of post-market safety data, including incident trends and risk-benefit evaluations, to ensure continued device safety and regulatory compliance.
Evaluate the overall benefit-risk profile of a medical device using clinical and post-market data to support regulatory compliance and lifecycle safety monitoring.
Prepare structured regulatory summaries and supporting documentation for FDA 510(k) submissions demonstrating device safety and substantial equivalence.
Align your AI roadmap with regulatory, medical, and commercial stakeholders without slowing down innovation.
Use LaunchAi as the backbone for your next generation of life sciences software products—whether you’re modernizing legacy platforms, launching new digital offerings, or embedding AI into existing workflows.
MedTech-Native AI Architecture
Unlike generic AI platforms, CapeStart's agents are pre-trained on MedTech regulatory frameworks, clinical ontologies, and reimbursement pathways — delivering domain-accurate outputs from day one.
Regulatory-Grade Data Governance
HIPAA, GDPR, FDA 21 CFR Part 11 compliant infrastructure ensures every agent interaction is auditable, traceable, and enterprise-ready for regulated environments.
Adaptive Multi-Agent Orchestration
Our proprietary orchestration layer coordinates specialized agents for data ingestion, analysis, synthesis, and output — with human-in-the-loop checkpoints where precision matters most.
Proven Scale & Speed
Deploy across enterprise workflows, reducing time-to-insight from weeks to hours. CapeStart agents operate 24/7, processing structured and unstructured MedTech data at scale.
Deep SME & Engineering Bench
600+ PHDs, Masters, Doctors, engineers, and domain experts in medical affairs, regulatory science, HEOR, and market access — ensuring AI outputs are grounded in real-world MedTech expertise.
Agents securely ingest from EHRs, regulatory databases, published literature, CRM systems, and proprietary data lakes via pre-built connectors.
Configure reporting templates, workflows, and output requirements through a no-code orchestration console tailored to your team’s needs.
Specialized AI agents autonomously process, cross-reference, and synthesize data using MedTech-specific reasoning models and evidence standards.
Reports are automatically validated against compliance rules, reviewed by SMEs when required, and delivered to your workflows in real time.
Agents improve with every interaction, incorporating feedback to sharpen accuracy and adapt to your organization’s evolving intelligence needs.
Explore how CapeStart’s agentic solutions address market access, clinical, regulatory, and commercial needs for technology leaders.
Agents synthesize clinical, economic, and real-world evidence to generate HTA-ready submission packages for NICE, G-BA, HAS, and other bodies — cutting preparation time by 70%.
Real-time monitoring of FDA, EU MDR, and clinical evidence requirements for 510(k), PMA, and CER, enabling proactive regulatory strategy and faster submissions.
Agents continuously mine PubMed, Embase, and clinical trial registries to build living evidence maps for clinical claims, product labeling, and publication planning.
Automated competitive tracking across filings, patents, congresses, clinical trials, and social signals — delivered as actionable intelligence to commercial teams.
Agents aggregate and analyze RWD from claims databases, registries, and EHRs to generate outcomes reports supporting coverage decisions and value negotiations.
Continuous MAUDE database and MDR mining with AI-driven signal detection, automated trend reporting, and regulatory submission assistance for vigilance teams.
Data Ingestion & Validation
Agents connect to 50+ MedTech data sources — clinical databases, FDA portals, literature repositories, and EHRs — with automated quality validation and entity resolution.
Domain-Specific Reasoning
Purpose-built reasoning models trained on MedTech taxonomies, ICD/CPT coding, IMDRF guidelines, and clinical ontologies ensure accurate, context-aware analysis.
Automated Report Assembly
Pre-validated templates for HTA, PSUR, 510(k), and market access reports are auto-populated with synthesized evidence, citations, and compliance checks built in.
Human-in-the-Loop Review
SME review gates at critical decision points ensure that agent-generated reports meet scientific and regulatory standards before delivery to stakeholders.
Multi-Format Delivery & Integration
Reports delivered via API, email, or integration with Veeva, Salesforce, SharePoint, and regulatory submission portals — wherever your teams work.
60% Reduction in Reporting Costs
Global Scale, Local Precision
Enterprise Security & Compliance
Living Intelligence That Evolves
LaunchAi won a 2025 Bronze Stevie® Award at the 22nd Annual International Business Awards® for its innovative AI/ML solution supporting life sciences content synthesis.
LaunchAi won a 2026 Artificial Intelligence Excellence Award from the Business Intelligence Group in the Generative AI category.
LaunchAi was included among PM360’s most innovative solutions in 2024.
CapeStart Inc is SOC 2 Type II compliant, confirming independent validation of our operational security controls and ongoing commitment to protecting customer data with strong governance and continuous monitoring.
CapeStart Inc is an AWS Partner (Select Tier), reflecting proven cloud delivery experience, certified AWS talent, and a track record of building secure, scalable solutions on AWS for enterprise teams.
Discover upcoming conferences, webinars, and roundtables where life sciences and AI leaders come together to see LaunchAi in action and engage with CapeStart experts.
